Type 1 Diabetes, characterized by an immune system assault on insulin-producing cells, demands lifelong insulin therapy. While historically associated with juveniles, it affects diverse age groups globally. This overview delves into its autoimmune origins, genetic predispositions, and the latest in management, highlighting the ongoing pursuit of a comprehensive understanding and eventual cure for this complex condition.